The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Association between non-alcoholic fatty liver disease and cancer incidence rate
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021 · cited 2×
“45) serves as a strong predictor of the absence of liver fibrosis.(13)”
BackgroundMethodEASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,336
Global burden of cancer attributable to high body-mass index in 2012: a population-based study
Arnold, M., Pandeya, N., Byrnes, G., Renehan, A. G., Stevens, G. A., Ezzati, M., Ferlay, J., Miranda, J. J., Romieu, I., Dikshit, R., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71123-4 · Cited by 997
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Ultrasound scanning in the detection of hepatic fibrosis and steatosis.
Saverymuttu, S. H., Joseph, A. E., & Maxwell, J. D. (1986) · BMJ · doi:10.1136/bmj.292.6512.13 · Cited by 853
Younossi, Z. M., Otgonsuren, M., Henry, L., Venkatesan, C., Mishra, A., Erario, M., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.28123 · Cited by 802 · cited 1×
“Recent data have shown that NAFLD is an attributable cause of HCC and indicated that the number of cases of NAFLD-related HCC in the United States increased 9% each year from 2004 to 2009.(8) Moreover, a cross-sectional study has demonstrated that patients with NAFLD, particularly those with NASH, are more likely to d…”
BackgroundKim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
Self-citationValidity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study
Dasarathy, S., Dasarathy, J., Khiyami, A., Joseph, R., Lopez, R., & McCullough, A. J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.09.001 · Cited by 656
Mittal, S., El-Serag, H. B., Sada, Y. H., Kanwal, F., Duan, Z., Temple, S., May, S. B., Kramer, J. R., Richardson, P. A., & Davila, J. A. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.019 · Cited by 648
Piscaglia, F., Svegliati‐Baroni, G., Barchetti, A., Pecorelli, A., Marinelli, S., Tiribelli, C., Bellentani, S., & on behalf of the HCC‐NAFLD Italian Study Group (2016) · Hepatology · doi:10.1002/hep.28368 · Cited by 604
Extrahepatic complications of nonalcoholic fatty liver disease
Armstrong, M. J., Adams, L. A., Canbay, A., & Syn, W.-K. (2014) · Hepatology · doi:10.1002/hep.26717 · Cited by 600
Gilbert, C. A., & Slingerland, J. M. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-121211-091527 · Cited by 302
Kawamura, Y., Arase, Y., Ikeda, K., Seko, Y., Imai, N., Hosaka, T., Kobayashi, M., Saitoh, S., Sezaki, H., Akuta, N., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.327 · Cited by 280 · cited 1×
“In addition, a high NFS or a high FIB-4 score showed strong association with the development of HCC, which corresponds with the results of previous studies.(16,32) However, no clear association between noninvasive fibrosis scores and the development of other cancers, including colorectal and breast cancer, was found i…”
ResultHigh prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis
Wong, V. W.-S., Wong, G. L.-H., Tsang, S. W.-C., Fan, T., Chu, W. C.-W., Woo, J., Chan, A. W.-H., Choi, P. C.-L., Chim, A. M.-L., Lau, J. Y.-W., et al. (2011) · Gut · doi:10.1136/gut.2011.237974 · Cited by 256
Park, S., Oh, C.-M., Cho, H., Lee, J. Y., Jung, K.-W., Jun, J. K., Won, Y.-J., Kong, H.-J., Choi, K. S., Lee, Y. J., et al. (2016) · BMJ · doi:10.1136/bmj.i5745 · Cited by 243
Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case–control study
Agnoli, C., Berrino, F., Abagnato, C. A., Muti, P., Panico, S., Crosignani, P., & Krogh, V. (2010) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.02.006 · Cited by 195
Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
Sanna, C., Rosso, C., Marietti, M., & Bugianesi, E. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050717 · Cited by 194
Lawlor, D. A., Smith, G. D., & Ebrahim, S. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000024225.14618.a8 · Cited by 182
Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma
Noureddin, M., & Rinella, M. E. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.012 · Cited by 181
Metabolic syndrome and the risk of breast cancer in postmenopausal women
Rosato, V., Bosetti, C., Talamini, R., Levi, F., Montella, M., Giacosa, A., Negri, E., & Vecchia, C. L. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr025 · Cited by 155
Campbell, P. T., Deka, A., Jacobs, E. J., Newton, C. C., Hildebrand, J. S., McCullough, M. L., Limburg, P. J., & Gapstur, S. M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.072 · Cited by 148
Choi, S.-Y., Kim, D., Kim, H. J., Kang, J. H., Chung, S. J., Park, M. J., Kim, Y. S., Kim, C. H., Choi, S. H., Kim, W. K., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.238 · Cited by 127
Self-citationKASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
(2013) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2013.19.4.325 · Cited by 125
Risk of Cancer in Patients Hospitalized With Fatty Liver
Sørensen, H. T., Mellemkjær, L., Jepsen, P., Thulstrup, A. M., Baron, J. A., Olsen, J. H., & Vilstrup, H. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200304000-00015 · Cited by 119
Visceral Fat Area and Markers of Insulin Resistance in Relation to Colorectal Neoplasia
Yamamoto, S., Nakagawa, T., Matsushita, Y., Kusano, S., Hayashi, T., Irokawa, M., Aoki, T., Korogi, Y., & Mizoue, T. (2009) · Diabetes Care · doi:10.2337/dc09-1197 · Cited by 113
Association of Obesity-Related Metabolic Disruptions With Cancer Risk and Outcome
Lohmann, A. E., Goodwin, P. J., Chlebowski, R. T., Pan, K., Stambolic, V., & Dowling, R. J. O. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.6187 · Cited by 101
Association of Metabolic Syndrome With Proximal and Synchronous Colorectal Neoplasm
Chiu, H., Lin, J., Shun, C., Liang, J., Lee, Y., Huang, S., & Wu, M. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.06.022 · Cited by 83
Non‐alcoholic fatty liver diseases and risk of colorectal neoplasia
Ahn, J., Sinn, D. H., Min, Y. W., Hong, S. N., Kim, H. S., Jung, S., Gu, S., Rhee, P., Paik, S. W., Son, H. J., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13866 · Cited by 68
Self-citationExtrahepatic Complications of Nonalcoholic Fatty Liver Disease
Chacko, K. R., & Reinus, J. F. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.004 · Cited by 67
Cited by
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Epidemiology of metabolic dysfunction-associated steatotic liver disease
Younossi, Z. M., Kalligeros, M., & Henry, L. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0431 · Cited by 960
Younossi, Z., Stepanova, M., Ong, J. P., Jacobson, I. M., Bugianesi, E., Duseja, A., Eguchi, Y., Wong, V. W., Negro, F., Yilmaz, Y., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.057 · Cited by 806
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
Le, M. H., Yeo, Y. H., Li, X., Li, J., Zou, B., Wu, Y., Ye, Q., Huang, D. Q., Zhao, C., Zhang, J., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.002 · Cited by 711
Metadata
- Authors
- Kim, G.-A., Lee, H. C., Choe, J., Kim, M.-J., Lee, M. J., Chang, H.-S., Bae, I. Y., Kim, H.-K., An, J., Shim, J. H., Kim, K. M., & Lim, Y.-S.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 68
- Issue
- 1
- Pages
- 140-146
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2770517007
- Cited by
- 331
- References
- 34
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.